Latest filing published 29 May 2024 for Annexin Pharmaceuticals AB (publ), €8,670. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Carl-Fredrik Lindner appears in our data through filings on Annexin Pharmaceuticals AB (publ) shares, published by Finansinspektionen. The record holds 8 filings, for trades running from 23 December 2020 to 29 May 2024.
Every open-market trade on record is a purchase: 7 purchases worth €23k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2024 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €525. None of the 7 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 29 May 2024, reports an open-market purchase of €8,670 in Annexin Pharmaceuticals AB (publ). Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations